List of Tables
Table 1. Global Paediatric Influenza Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Oseltamivir
Table 3. Key Players of Zanamivir
Table 4. Key Players of Amantadine
Table 5. Key Players of Rimantadine
Table 6. Key Players of Other
Table 7. Global Paediatric Influenza Treatment Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Paediatric Influenza Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Paediatric Influenza Treatment Market Size by Region (US$ Million), 2021–2026
Table 10. Global Paediatric Influenza Treatment Market Share by Region (2021–2026)
Table 11. Global Paediatric Influenza Treatment Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Paediatric Influenza Treatment Market Share by Region (2027–2032)
Table 13. Paediatric Influenza Treatment Market Trends
Table 14. Paediatric Influenza Treatment Market Drivers
Table 15. Paediatric Influenza Treatment Market Challenges
Table 16. Paediatric Influenza Treatment Market Restraints
Table 17. Global Paediatric Influenza Treatment Revenue by Players (US$ Million), 2021–2026
Table 18. Global Paediatric Influenza Treatment Market Share by Players (2021–2026)
Table 19. Global Top Paediatric Influenza Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Paediatric Influenza Treatment Revenue, 2025
Table 20. Ranking of Global Top Paediatric Influenza Treatment Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Paediatric Influenza Treatment Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Paediatric Influenza Treatment, Headquarters and Area Served
Table 23. Global Key Players of Paediatric Influenza Treatment, Products and Applications
Table 24. Global Key Players of Paediatric Influenza Treatment, Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Paediatric Influenza Treatment Market Size by Type (US$ Million), 2021–2026
Table 27. Global Paediatric Influenza Treatment Revenue Market Share by Type (2021–2026)
Table 28. Global Paediatric Influenza Treatment Forecasted Market Size by Type (US$ Million), 2027–2032
Table 29. Global Paediatric Influenza Treatment Revenue Market Share by Type (2027–2032)
Table 30. Global Paediatric Influenza Treatment Market Size by Application (US$ Million), 2021–2026
Table 31. Global Paediatric Influenza Treatment Revenue Market Share by Application (2021–2026)
Table 32. Global Paediatric Influenza Treatment Forecasted Market Size by Application (US$ Million), 2027–2032
Table 33. Global Paediatric Influenza Treatment Revenue Market Share by Application (2027–2032)
Table 34. North America Paediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Paediatric Influenza Treatment Market Size by Country (US$ Million), 2021–2026
Table 36. North America Paediatric Influenza Treatment Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Paediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Paediatric Influenza Treatment Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Paediatric Influenza Treatment Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Paediatric Influenza Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Paediatric Influenza Treatment Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Paediatric Influenza Treatment Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Paediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Paediatric Influenza Treatment Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Paediatric Influenza Treatment Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Paediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Paediatric Influenza Treatment Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Paediatric Influenza Treatment Market Size by Country (US$ Million), 2027–2032
Table 49. GlaxoSmithKline Company Details
Table 50. GlaxoSmithKline Business Overview
Table 51. GlaxoSmithKline Paediatric Influenza Treatment Product
Table 52. GlaxoSmithKline Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 53. GlaxoSmithKline Recent Development
Table 54. NATCO Pharma Company Details
Table 55. NATCO Pharma Business Overview
Table 56. NATCO Pharma Paediatric Influenza Treatment Product
Table 57. NATCO Pharma Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 58. NATCO Pharma Recent Development
Table 59. NESHER PHARMS Company Details
Table 60. NESHER PHARMS Business Overview
Table 61. NESHER PHARMS Paediatric Influenza Treatment Product
Table 62. NESHER PHARMS Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 63. NESHER PHARMS Recent Development
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Paediatric Influenza Treatment Product
Table 67. Roche Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 68. Roche Recent Development
Table 69. Atabay Kimya Sanayi ve Ticaret Company Details
Table 70. Atabay Kimya Sanayi ve Ticaret Business Overview
Table 71. Atabay Kimya Sanayi ve Ticaret Paediatric Influenza Treatment Product
Table 72. Atabay Kimya Sanayi ve Ticaret Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 73. Atabay Kimya Sanayi ve Ticaret Recent Development
Table 74. Cipla Company Details
Table 75. Cipla Business Overview
Table 76. Cipla Paediatric Influenza Treatment Product
Table 77. Cipla Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 78. Cipla Recent Development
Table 79. Hetero Pharma Company Details
Table 80. Hetero Pharma Business Overview
Table 81. Hetero Pharma Paediatric Influenza Treatment Product
Table 82. Hetero Pharma Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 83. Hetero Pharma Recent Development
Table 84. Teva Pharmaceutical Company Details
Table 85. Teva Pharmaceutical Business Overview
Table 86. Teva Pharmaceutical Paediatric Influenza Treatment Product
Table 87. Teva Pharmaceutical Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 88. Teva Pharmaceutical Recent Development
Table 89. Olainfarm Company Details
Table 90. Olainfarm Business Overview
Table 91. Olainfarm Paediatric Influenza Treatment Product
Table 92. Olainfarm Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 93. Olainfarm Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. Paediatric Influenza Treatment Picture
Figure 2. Global Paediatric Influenza Treatment Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Paediatric Influenza Treatment Market Share by Type: 2025 vs 2032
Figure 4. Oseltamivir Features
Figure 5. Zanamivir Features
Figure 6. Amantadine Features
Figure 7. Rimantadine Features
Figure 8. Other Features
Figure 9. Global Paediatric Influenza Treatment Market Size by Application (US$ Million), 2021–2032
Figure 10. Global Paediatric Influenza Treatment Market Share by Application: 2025 vs 2032
Figure 11. Hospital Case Studies
Figure 12. Retail Pharmacy Case Studies
Figure 13. Other Case Studies
Figure 14. Paediatric Influenza Treatment Report Years Considered
Figure 15. Global Paediatric Influenza Treatment Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Paediatric Influenza Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Paediatric Influenza Treatment Market Share by Region: 2025 vs 2032
Figure 18. Global Paediatric Influenza Treatment Market Share by Players in 2025
Figure 19. Global Paediatric Influenza Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Paediatric Influenza Treatment Revenue in 2025
Figure 21. North America Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Paediatric Influenza Treatment Market Share by Country (2021–2032)
Figure 23. United States Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Paediatric Influenza Treatment Market Share by Country (2021–2032)
Figure 27. Germany Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Paediatric Influenza Treatment Market Share by Region (2021–2032)
Figure 35. China Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Paediatric Influenza Treatment Market Share by Country (2021–2032)
Figure 43. Mexico Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Paediatric Influenza Treatment Market Share by Country (2021–2032)
Figure 47. Israel Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. GlaxoSmithKline Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 51. NATCO Pharma Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 52. NESHER PHARMS Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 53. Roche Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 54. Atabay Kimya Sanayi ve Ticaret Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 55. Cipla Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 56. Hetero Pharma Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 57. Teva Pharmaceutical Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 58. Olainfarm Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
